Deep Dive
Stephanie's diagnosis and the impossible choice
In 2021, Stephanie discovered a spot on her arm while at Disney World. Testing revealed stage four melanoma that had already spread to her brain and lungs. After two years of immunotherapy, the cancer began retreating but the treatment ravaged her joints — she couldn't climb stairs, open jars, or drive without crippling pain. Two separate doctors concluded she needed Infliximab, a drug to manage her joint inflammation, while continuing cancer treatment. But her insurance company denied the medication, claiming it didn't meet guidelines and was experimental. Stephanie appealed twice. Denied both times. She faced an impossible choice: stay on cancer treatment and suffer unbearable joint pain, or quit immunotherapy and risk the cancer returning.
How insurance companies weaponize denial denial
Doctor Mike uses the banking analogy to explain insurers' incentive structure. Just as banks lend out deposited money to generate profit, insurers collect premiums upfront knowing they won't have enough to cover simultaneous claims from all customers. They must set guardrails — deductibles, exclusions, step therapy requirements — to manage cash flow. But publicly traded insurers face shareholder pressure to maximize profit, not minimize patient denials. The strategy is deliberate: raise denial rates by a few percentage points, betting that most patients will be too confused or exhausted to appeal. The numbers prove it works. Insurers deny 850 million claims annually. Less than 1% get appealed. Yet when patients do appeal, they win over 50% of the time. That gap between denials and successful appeals is pure profit extracted from people's despair.
The appeal playbook and the AI shortcut
Doctor Mike walks through the appeal checklist. First, identify the exact denial reason — not medically necessary, experimental, or step therapy required. Second, build an evidence file: doctor's notes, prior authorizations, clinical research, proof of what you've already tried. Third, cite your policy language and relevant state laws. Most patients don't know insurers break their own contracts regularly and that law is on the patient's side. Fourth, write a personal impact statement — appeals get reviewed by humans making subjective calls, and emotional resonance matters. Fifth, blast your appeal to multiple recipients: state insurance department, attorney general, department of labor, employer leadership, congressional representatives. Surface area increases pressure. Sixth, request an independent medical review, a state-mandated process that removes the insurer entirely. Stephanie used Claimable, an AI platform that automates this. The software organized her documentation, crafted a legally optimized appeal, and targeted her specific insurer and policy. Two days later: approved.
The victory and the permanent cost
Stephanie won her appeal but the insurer's excuse revealed the whole game was arbitrary. They claimed a 'processing error involving a misapplication of policy' and said there was 'no intent to deny care.' Translation: the system got it wrong, probably an AI glitch or staff mistake, but Stephanie had to fight for nine months to surface it. During those nine months waiting for Infliximab, the joint inflammation caused irreparable damage to her hands. She won the coverage fight but lost permanent mobility. Doctor Mike closes by naming other AI appeals platforms — Counterforce Health, Fight Health Insurance, Appeal Armor — and urging viewers to use them. The message is clear: insurers count on your surrender. Refusing to surrender costs them money.